The Science on Coronavirus is Topsy-Turvy. That's Fine.
Urgency demands patience, because advancement is always a product of missteps.
Contradiction is a constant in the Covid-19 crisis.
Peter Bach and Kent Sepkowitz write in the New York Times how every new test and treatment must be assessed against those that came before it. Progress in the medical field has always come with missteps, and its history is one of rare successes sprinkled among many failures. Dr. Peter Bach proposes we should continue to monitor disease fluctuations through a population registry, compiling individual diagnostic test results and disease history among other information. Diagnostic tests could be compared in real time, and those who could be approached for trials of early treatment could be identified. This way, insights can be gathered quickly including the contradictions they will contain.
Read the full article here.